Double-blind, randomized, multicentre study of the efficacy and safety of gliclazide-modified release in the treatment of Chinese type 2 diabetic patients-Reference-Cited by-同舟云学术

Double-blind, randomized, multicentre study of the efficacy and safety of gliclazide-modified release in the treatment of Chinese type 2 diabetic patients

Published:2006-03 Issue:2 Volume:8 Page:184-191
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Lu C.-H.,Chang C.-C.,Chuang L.-M.,Wang C. Y.,Jiang Y. D.,Wu H. P.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2005.00501.x/fullpdf

Reference15 articles.

1. 2 World Health Organization. Prevention of Diabetes Mellitus. Geneva: WHO, Technical Report Series, 1994 : 844 .

2. Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie U.S.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating Gliclazide Safety and Effectiveness in the Management of Type 2 Diabetes Mellitus;International Journal of Innovative Science and Research Technology (IJISRT);2024-07-12

2. Comparison of gliclazide vs linagliptin on hypoglycemia and cardiovascular events in type 2 diabetes mellitus: A systematic review;World Journal of Diabetes;2022-12-15

3. Development and Bio-Predictive Evaluation of Biopharmaceutical Properties of Sustained-Release Tablets with a Novel GPR40 Agonist for a First-in-Human Clinical Trial;Pharmaceutics;2021-05-28

4. Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records;Drugs - Real World Outcomes;2020-07-09

5. The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide;Canadian Journal of Diabetes;2015-11